Universal Ibogaine Inc. (IBOGF) Research

Universal Ibogaine Inc., a life sciences enterprise, focuses on developing, acquiring, and operating addiction treatment centers across Canada. The company is additionally preparing to launch clinical trials aimed at researching ibogaine's potential therapeutic applications for addiction. Its principal corporate offices are based in Calgary, Canada.

Market snapshot

Symbol
IBOGF
Price
$0.02
Day change
+9.39%
Market cap
$1.6M
P/E ratio
-4.16x
52-week range
0.0023-0.35
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • America Great Health (AAGH)
  • Ayala Pharmaceuticals, Inc. (ADXS)
  • Algernon Pharmaceuticals Inc. (AGNPF)
  • Appili Therapeutics Inc. (APLIF)
  • Genix Pharmaceuticals Corporation (GENPF)
  • Galera Therapeutics, Inc. (GRTX)
  • Health Sciences Group, Inc. (HESG)
  • Restart Life Sciences Corp. (NMLSF)

Open Universal Ibogaine Inc. (IBOGF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.